Search Results

One moment please while the data are loaded...

The DNTP Technical Report (TR) Level of Evidence Criteria are available here: https://ntp.niehs.nih.gov/go/baresults. In the table below this information is further delineated into three fields:

Level of Evidence: The overall category of evidence of carcinogenic activity for the TR, Species, Strain and Sex
Organ Site Call: The level of evidence supported by the specific organ site for the TR, Species, Strain and Sex. When the Organ Site Call directly supports the TR Level Of Evidence the Finding Type flag is set to “Neoplastic Lesion”. Some Organ Site Calls could support a separate call of Equivocal Evidence; this is noted in Finding Type by the flag “May Have Been Related”
Finding Type: Further identification of the Organ Site Call. Where this says “Neoplastic Lesion” the Organ Site Call supports the TR Level of Evidence and the Organ Site Call is the same as that of the TR. Where Finding Type says “May Have Been Related” the TR Level of Evidence for other responses led to an overall call of Clear or Some Evidence but the specified organ supports a call of Equivocal Evidence.

Displays results that match exactly with the given criteria.
Exact Match	Publication No.	CASRN	Test Article Name	Species	Strain	Sex	Route	Organ	Level of Evidence	Organ Site Call	Tumor Type/Incidence	Finding Type
Yes	TR-006	18662-53-8	Nitrilotriacetic acid trisodium monohydrate	Rats	F344/N	Male	Dosed-Feed	Kidney Transitional Cell	Positive	Positive	CARCINOMA	Neoplastic Lesions
Yes	TR-089	134-29-2	o-Anisidine hydrochloride	Rats	F344/N	Male	Dosed-Feed	Kidney Transitional Cell	Positive	Positive	CARCINOMA	Neoplastic Lesions
Yes	TR-423	119-84-6	3,4-Dihydrocoumarin	Rats	F344/N	Male	Gavage	Kidney Transitional Cell	Some Evidence	Equivocal Evidence	CARCINOMA 0/50 0/48 0/47 2/50	May Have Been Related
Yes	TR-367	50-33-9	Phenylbutazone	Rats	F344/N	Female	Gavage	Kidney Transitional Cell	Some Evidence	Some Evidence	CARCINOMA 0/50 0/50 2/50	Neoplastic Lesions
Yes	TR-416	91-23-6	o-Nitroanisole	Rats	F344/N	Female	Dosed-Feed	Kidney Transitional Cell	Clear Evidence	Clear Evidence	(STOP STUDY) PAPILLOMA 0/60 0/60 1/60 OR CARCINOMA 0/60 0/60 1/60	Neoplastic Lesions
Yes	TR-416	91-23-6	o-Nitroanisole	Rats	F344/N	Male	Dosed-Feed	Kidney Transitional Cell	Clear Evidence	Clear Evidence	PAPILLOMA (STOP STUDY) 0/60 0/60 4/60 OR CARCINOMA 0/60 1/60 8/60	Neoplastic Lesions
Yes	TR-335	6373-74-6	C.I. Acid Orange 3	Rats	F344/N	Female	Gavage	Kidney Transitional Cell	Clear Evidence	Clear Evidence	CARCINOMA 0/50 0/50 6/50	Neoplastic Lesions
Yes	TR-323	756-79-6	Dimethyl methylphosphonate	Rats	F344/N	Male	Gavage	Kidney Transitional Cell	Some Evidence	Some Evidence	PAPILLOMA 0/50 7/50 3/49	Neoplastic Lesions
Yes	TR-313	2385-85-5	Mirex	Rats	F344/N	Male	Dosed-Feed	Kidney Transitional Cell	Clear Evidence	Clear Evidence	PAPILLOMA 0/51 0/51 0/52 0/52 1/51 3/52	Neoplastic Lesions
Yes	TR-494	84-65-1	Anthraquinone	Rats	F344/N	Male	Dosed-Feed	Kidney Transitional Cell	Some Evidence	Some Evidence	PAPILLOMA 0/50 0/50 2/50 0/50 1/50	Neoplastic Lesions
Yes	TR-457	599-79-1	Salicylazosulfapyridine	Rats	F344/N	Female	Gavage	Kidney Transitional Cell	Some Evidence	Some Evidence	PAPILLOMA 0/50 0/50 0/50 2/50	Neoplastic Lesions

Displays all results in TRs which have data that match the given criteria.
Exact Match	Publication No.	CASRN	Test Article Name	Species	Strain	Sex	Route	Organ	Level of Evidence	Organ Site Call	Tumor Type/Incidence	Finding Type
No	TR-423	119-84-6	3,4-Dihydrocoumarin	Mice	B6C3F1	Male	Gavage	Unspecified	No Evidence		Not applicable	Not applicable
Yes	TR-423	119-84-6	3,4-Dihydrocoumarin	Rats	F344/N	Male	Gavage	Kidney Transitional Cell	Some Evidence	Equivocal Evidence	CARCINOMA 0/50 0/48 0/47 2/50	May Have Been Related
No	TR-423	119-84-6	3,4-Dihydrocoumarin	Rats	F344/N	Male	Gavage	Kidney Tubular Cell	Some Evidence	Some Evidence	ADENOMA 0/50 1/48 0/47 2/50, STEP SECTIONS 1/50 0/48 3/47 5/50	Neoplastic Lesions
No	TR-423	119-84-6	3,4-Dihydrocoumarin	Mice	B6C3F1	Female	Gavage	Liver	Some Evidence	Some Evidence	ADENOMA 10/51 20/50 22/50 20/52 OR CARCINOMA 3/51 2/50 4/50 6/52 COMBINED 13/51 21/50 25/50 24/52	Neoplastic Lesions
Yes	TR-494	84-65-1	Anthraquinone	Rats	F344/N	Male	Dosed-Feed	Kidney Transitional Cell	Some Evidence	Some Evidence	PAPILLOMA 0/50 0/50 2/50 0/50 1/50	Neoplastic Lesions
No	TR-494	84-65-1	Anthraquinone	Rats	F344/N	Female	Dosed-Feed	Kidney Tubular Cell	Clear Evidence	Clear Evidence	ADENOMA 0/50 4/50 9/50 7/50 12/49; ADENOMA OR CARCINOMA 0/50 6/50 9/50 8/50 14/49	Neoplastic Lesions
No	TR-494	84-65-1	Anthraquinone	Rats	F344/N	Male	Dosed-Feed	Kidney Tubular Cell	Some Evidence	Some Evidence	ADENOMA 1/50 3/50 9/50 5/50 3/50	Neoplastic Lesions
No	TR-494	84-65-1	Anthraquinone	Rats	F344/N	Male	Dosed-Feed	Liver	Some Evidence	Equivocal Evidence	ADENOMA OR CARCINOMA 1/50 3/50 4/50 5/50 3/50	May Have Been Related
No	TR-494	84-65-1	Anthraquinone	Mice	B6C3F1	Female	Dosed-Feed	Liver	Clear Evidence	Clear Evidence	ADENOMA 6/49 28/50 27/50 40/49 OR CARCINOMA 2/49 3/50 8/50 8/49 COMBINED 6/49 30/50 30/50 41/49	Neoplastic Lesions
No	TR-494	84-65-1	Anthraquinone	Mice	B6C3F1	Male	Dosed-Feed	Liver	Clear Evidence	Clear Evidence	ADENOMA 21/50 32/50 38/50 41/49 OR CARCINOMA 8/50 13/50 17/50 21/49 OR HEPATOBLASTOMA 1/50 6/50 11/50 37/49 COMBINED 26/50 35/50 43/50 48/49	Neoplastic Lesions
No	TR-494	84-65-1	Anthraquinone	Rats	F344/N	Female	Dosed-Feed	Liver	Clear Evidence	Clear Evidence	ADENOMA 0/50 2/50 6/50 4/50 3/50	Neoplastic Lesions
No	TR-494	84-65-1	Anthraquinone	Mice	B6C3F1	Female	Dosed-Feed	Thyroid Gland Follicular Cell	Clear Evidence	Equivocal Evidence	ADENOMA 1/45 1/48 2/48 2/48 OR CARCINOMA 0/45 0/48 0/48 2/48 COMBINED 1/45 1/48 2/48 4/48	May Have Been Related
No	TR-494	84-65-1	Anthraquinone	Mice	B6C3F1	Male	Dosed-Feed	Thyroid Gland Follicular Cell	Clear Evidence	Equivocal Evidence	ADENOMA 0/50 0/50 2/49 2/46	May Have Been Related
No	TR-494	84-65-1	Anthraquinone	Rats	F344/N	Female	Dosed-Feed	Urinary Bladder	Clear Evidence	Clear Evidence	TRANSITIONAL EPITHELIAL PAPILLOMA OR CARCINOMA 0/49 0/49 0/49 1/50 2/49	Neoplastic Lesions
No	TR-494	84-65-1	Anthraquinone	Rats	F344/N	Male	Dosed-Feed	Urinary Bladder	Some Evidence	Some Evidence	TRANSITIONAL EPITHELIAL PAPILLOMA 0/50 1/50 3/50 7/50 3/49	Neoplastic Lesions
Yes	TR-335	6373-74-6	C.I. Acid Orange 3	Rats	F344/N	Female	Gavage	Kidney Transitional Cell	Clear Evidence	Clear Evidence	CARCINOMA 0/50 0/50 6/50	Neoplastic Lesions
No	TR-323	756-79-6	Dimethyl methylphosphonate	Mice	B6C3F1	Male	Gavage	Unspecified	Inadequate Study		Not applicable	Not applicable
No	TR-323	756-79-6	Dimethyl methylphosphonate	Mice	B6C3F1	Female	Gavage	Unspecified	No Evidence		Not applicable	Not applicable
No	TR-323	756-79-6	Dimethyl methylphosphonate	Rats	F344/N	Female	Gavage	Unspecified	No Evidence		Not applicable	Not applicable
No	TR-323	756-79-6	Dimethyl methylphosphonate	Rats	F344/N	Male	Gavage	Hematopoietic System	Some Evidence	Equivocal Evidence	LEUKEMIA 10/50 11/50 17/50	May Have Been Related
Yes	TR-323	756-79-6	Dimethyl methylphosphonate	Rats	F344/N	Male	Gavage	Kidney Transitional Cell	Some Evidence	Some Evidence	PAPILLOMA 0/50 7/50 3/49	Neoplastic Lesions
No	TR-323	756-79-6	Dimethyl methylphosphonate	Rats	F344/N	Male	Gavage	Kidney Tubular Cell	Some Evidence	Some Evidence	ADENOCARCINOMA 0/50 2/50 3/49	Neoplastic Lesions
No	TR-313	2385-85-5	Mirex	Rats	F344/N	Male	Dosed-Feed	Adrenal Gland Medulla	Clear Evidence	Clear Evidence	PHEOCHROMOCYTOMA 8/51 7/52 13/52 11/52 18/51 19/51	Neoplastic Lesions
No	TR-313	2385-85-5	Mirex	Rats	F344/N	Female	Dosed-Feed	Hematopoietic System	Clear Evidence	Clear Evidence	LEUKEMIA 6/52 9/52 14/52	Neoplastic Lesions
Yes	TR-313	2385-85-5	Mirex	Rats	F344/N	Male	Dosed-Feed	Kidney Transitional Cell	Clear Evidence	Clear Evidence	PAPILLOMA 0/51 0/51 0/52 0/52 1/51 3/52	Neoplastic Lesions
No	TR-313	2385-85-5	Mirex	Rats	F344/N	Female	Dosed-Feed	Liver	Clear Evidence	Clear Evidence	NEOPLASTIC NODULE 2/52 23/52 30/52	Neoplastic Lesions
No	TR-313	2385-85-5	Mirex	Rats	F344/N	Male	Dosed-Feed	Liver	Clear Evidence	Clear Evidence	NEOPLASTIC NODULE 3/52 5/52 5/52 14/52 15/52 26/52	Neoplastic Lesions
No	TR-006	139-13-9	Nitrilotriacetic acid (NTA)	Mice	B6C3F1	Female	Dosed-Feed	Kidney Tubular Cell	Positive	Positive	ADENOCARCINOMA	Neoplastic Lesions
No	TR-006	139-13-9	Nitrilotriacetic acid (NTA)	Mice	B6C3F1	Male	Dosed-Feed	Kidney Tubular Cell	Positive	Positive	ADENOCARCINOMA	Neoplastic Lesions
No	TR-006	139-13-9	Nitrilotriacetic acid (NTA)	Rats	F344/N	Male	Dosed-Feed	Kidney Tubular Cell	Positive	Positive	ADENOMA OR ADENOCARCINOMA	Neoplastic Lesions
No	TR-006	139-13-9	Nitrilotriacetic acid (NTA)	Rats	F344/N	Male	Dosed-Feed	Ureter	Positive	Positive	(ADENOMA OR PAPILLOMA)	Neoplastic Lesions
No	TR-006	139-13-9	Nitrilotriacetic acid (NTA)	Rats	F344/N	Female	Dosed-Feed	Urinary Bladder	Positive	Positive	(TRANSITIONAL CELL CARCINOMA)	Neoplastic Lesions
No	TR-006	18662-53-8	Nitrilotriacetic acid trisodium monohydrate	Mice	B6C3F1	Female	Dosed-Feed	Unspecified	Negative		Not applicable	Not applicable
No	TR-006	18662-53-8	Nitrilotriacetic acid trisodium monohydrate	Mice	B6C3F1	Male	Dosed-Feed	Unspecified	Negative		Not applicable	Not applicable
No	TR-006	18662-53-8	Nitrilotriacetic acid trisodium monohydrate	Rats	F344/N	Male	Dosed-Feed	Kidney Transitional Cell	Equivocal Evidence	Equivocal	PAPILLOMA	Neoplastic Lesions
Yes	TR-006	18662-53-8	Nitrilotriacetic acid trisodium monohydrate	Rats	F344/N	Male	Dosed-Feed	Kidney Transitional Cell	Positive	Positive	CARCINOMA	Neoplastic Lesions
No	TR-006	18662-53-8	Nitrilotriacetic acid trisodium monohydrate	Rats	F344/N	Male	Dosed-Feed	Kidney Tubular Cell	Equivocal Evidence	Equivocal	ADENOCARCINOMA	Neoplastic Lesions
No	TR-006	18662-53-8	Nitrilotriacetic acid trisodium monohydrate	Rats	F344/N	Female	Dosed-Feed	Kidney Tubular Cell	Positive	Positive	ADENOMA OR ADENOCARCINOMA	Neoplastic Lesions
No	TR-006	18662-53-8	Nitrilotriacetic acid trisodium monohydrate	Rats	F344/N	Male	Dosed-Feed	Kidney Tubular Cell	Positive	Positive	ADENOCARCINOMA OR CARCINOMA	Neoplastic Lesions
No	TR-006	18662-53-8	Nitrilotriacetic acid trisodium monohydrate	Rats	F344/N	Female	Dosed-Feed	Ureter	Positive	Positive	(TRANSITIONAL CELL CARCINOMA)	Neoplastic Lesions
No	TR-006	18662-53-8	Nitrilotriacetic acid trisodium monohydrate	Rats	F344/N	Male	Dosed-Feed	Ureter	Positive	Positive	(TRANSITIONAL CELL CARCINOMA)	Neoplastic Lesions
No	TR-006	18662-53-8	Nitrilotriacetic acid trisodium monohydrate	Rats	F344/N	Female	Dosed-Feed	Urinary Bladder	Equivocal Evidence	Equivocal	(TRANSITIONAL CELL CARCINOMA)	Neoplastic Lesions
No	TR-006	18662-53-8	Nitrilotriacetic acid trisodium monohydrate	Rats	F344/N	Female	Dosed-Feed	Urinary Bladder	Positive	Positive	(TRANSITIONAL CELL CARCINOMA)	Neoplastic Lesions
Yes	TR-089	134-29-2	o-Anisidine hydrochloride	Rats	F344/N	Male	Dosed-Feed	Kidney Transitional Cell	Positive	Positive	CARCINOMA	Neoplastic Lesions
No	TR-089	134-29-2	o-Anisidine hydrochloride	Rats	F344/N	Male	Dosed-Feed	Thyroid Gland Follicular Cell	Positive	Positive	ADENOMA OR CARCINOMA	Neoplastic Lesions
No	TR-089	134-29-2	o-Anisidine hydrochloride	Mice	B6C3F1	Female	Dosed-Feed	Urinary Bladder	Positive	Positive	(TRANSITIONAL CELL PAPILLOMA, TRANSITIONAL CELL CARCINOMA)	Neoplastic Lesions
No	TR-089	134-29-2	o-Anisidine hydrochloride	Mice	B6C3F1	Male	Dosed-Feed	Urinary Bladder	Positive	Positive	(TRANSITIONAL CELL PAPILLOMA, TRANSITIONAL CELL CARCINOMA)	Neoplastic Lesions
No	TR-089	134-29-2	o-Anisidine hydrochloride	Rats	F344/N	Female	Dosed-Feed	Urinary Bladder	Positive	Positive	(TRANSITIONAL CELL PAPILLOMA, TRANSITIONAL CELL CARCINOMA)	Neoplastic Lesions
No	TR-089	134-29-2	o-Anisidine hydrochloride	Rats	F344/N	Male	Dosed-Feed	Urinary Bladder	Positive	Positive	(TRANSITIONAL CELL PAPILLOMA, TRANSITIONAL CELL CARCINOMA)	Neoplastic Lesions
No	TR-416	91-23-6	o-Nitroanisole	Rats	F344/N	Female	Dosed-Feed	Forestomach	Clear Evidence	Equivocal Evidence	SQUAMOUS CELL PAPILLOMA 0/50 1/50 0/50 1/50	May Have Been Related
No	TR-416	91-23-6	o-Nitroanisole	Rats	F344/N	Male	Dosed-Feed	Forestomach	Clear Evidence	Equivocal Evidence	SQUAMOUS CELL PAPILLOMA O/50 0/50 1/50 1/50; SQUAMOUS CELL CARCINOMA 0/50 0/50 1/50 1/50	May Have Been Related
No	TR-416	91-23-6	o-Nitroanisole	Rats	F344/N	Female	Dosed-Feed	Hematopoietic System	Clear Evidence	Clear Evidence	MONONUCLEAR CELL LEUKEMIA 14/50 11/50 14/50 26/50	Neoplastic Lesions
No	TR-416	91-23-6	o-Nitroanisole	Rats	F344/N	Male	Dosed-Feed	Hematopoietic System	Clear Evidence	Clear Evidence	MONONUCLEAR CELL LEUKEMIA 26/50 25/50 42/50 34/50	Neoplastic Lesions
No	TR-416	91-23-6	o-Nitroanisole	Rats	F344/N	Female	Dosed-Feed	Intestines (Large)	Clear Evidence	Clear Evidence	(STOP STUDY) ADENOMATOUS POLYP 0/60 8/60 18/60, CARCINOMA 0/60 0/60 2/60	Neoplastic Lesions
No	TR-416	91-23-6	o-Nitroanisole	Rats	F344/N	Male	Dosed-Feed	Intestines (Large)	Clear Evidence	Clear Evidence	(STOP STUDY) ADENOMATOUS POLYP 0/60 26/60 30/60, CARCINOMA 0/60 0/60 5/60	Neoplastic Lesions
Yes	TR-416	91-23-6	o-Nitroanisole	Rats	F344/N	Female	Dosed-Feed	Kidney Transitional Cell	Clear Evidence	Clear Evidence	(STOP STUDY) PAPILLOMA 0/60 0/60 1/60 OR CARCINOMA 0/60 0/60 1/60	Neoplastic Lesions
Yes	TR-416	91-23-6	o-Nitroanisole	Rats	F344/N	Male	Dosed-Feed	Kidney Transitional Cell	Clear Evidence	Clear Evidence	PAPILLOMA (STOP STUDY) 0/60 0/60 4/60 OR CARCINOMA 0/60 1/60 8/60	Neoplastic Lesions
No	TR-416	91-23-6	o-Nitroanisole	Rats	F344/N	Male	Dosed-Feed	Kidney Tubular Cell	Clear Evidence	Equivocal Evidence	ADENOMA 0/49 1/50 1/50 1/49 OR CARCINOMA 0/49 0/50 0/50 2/49	May Have Been Related
No	TR-416	91-23-6	o-Nitroanisole	Mice	B6C3F1	Male	Dosed-Feed	Liver	Clear Evidence	Clear Evidence	ADENOMA 14/50 26/50 41/50 29/50; CARCINOMA 7/50 12/50 11/50 7/50; HEPATOBLASTOMA 0/50 3/50 17/50 9/50	Neoplastic Lesions
No	TR-416	91-23-6	o-Nitroanisole	Mice	B6C3F1	Female	Dosed-Feed	Liver	Some Evidence	Some Evidence	ADENOMA 14/50 2/50 36/50 18/50	Neoplastic Lesions
No	TR-416	91-23-6	o-Nitroanisole	Rats	F344/N	Female	Dosed-Feed	Urinary Bladder	Clear Evidence	Clear Evidence	(STOP STUDY) TRANSITIONAL CELL PAPILLOMA 0/58 2/59 1/60, TRANSITIONAL CELL CARCINOMA 0/58 28/59 48/60	Neoplastic Lesions
No	TR-416	91-23-6	o-Nitroanisole	Rats	F344/N	Male	Dosed-Feed	Urinary Bladder	Clear Evidence	Clear Evidence	(STOP STUDY) TRANSITIONAL CELL PAPILLOMA 0/59 9/59 1/60, TRANSITIONAL CELL CARCINOMA 0/59 27/59 50/60, SQUAMOUS CELL PAPILLOMA 0/59 0/59 4/60, SQUAMOUS CELL CARCINOMA 0/59 0/59 6/60, SARCOMA 0/59 2/59 9/60	Neoplastic Lesions
No	TR-367	50-33-9	Phenylbutazone	Mice	B6C3F1	Female	Gavage	Unspecified	No Evidence		Not applicable	Not applicable
Yes	TR-367	50-33-9	Phenylbutazone	Rats	F344/N	Female	Gavage	Kidney Transitional Cell	Some Evidence	Some Evidence	CARCINOMA 0/50 0/50 2/50	Neoplastic Lesions
No	TR-367	50-33-9	Phenylbutazone	Rats	F344/N	Female	Gavage	Kidney Tubular Cell	Some Evidence	Equivocal Evidence	ADENOMA (STEP SECTIONS) 0/50 3/50 1/50 OR CARCINOMA 0/50 1/50 0/50 COMBINED 0/50 4/50 1/50	May Have Been Related
No	TR-367	50-33-9	Phenylbutazone	Rats	F344/N	Male	Gavage	Kidney Tubular Cell	Equivocal Evidence	Equivocal Evidence	ADENOMA 0/50 0/49 3/50 OR CARCINOMA 0/50 1/49 0/50 COMBINED 0/50 1/49 3/50	Neoplastic Lesions
No	TR-367	50-33-9	Phenylbutazone	Mice	B6C3F1	Male	Gavage	Liver	Some Evidence	Some Evidence	ADENOMA 8/50 12/50 24/50 OR CARCINOMA 8/50 4/50 11/50 COMBINED 16/50 14/50 31/50	Neoplastic Lesions
Yes	TR-457	599-79-1	Salicylazosulfapyridine	Rats	F344/N	Female	Gavage	Kidney Transitional Cell	Some Evidence	Some Evidence	PAPILLOMA 0/50 0/50 0/50 2/50	Neoplastic Lesions
No	TR-457	599-79-1	Salicylazosulfapyridine	Mice	B6C3F1	Female	Gavage	Liver	Clear Evidence	Clear Evidence	ADENOMA 12/50 28/50 25/50 28/49 OR CARCINOMA 2/50 10/50 10/50 9/49 COMBINED 14/50 32/50 28/50 29/49	Neoplastic Lesions
No	TR-457	599-79-1	Salicylazosulfapyridine	Mice	B6C3F1	Male	Gavage	Liver	Clear Evidence	Clear Evidence	ADENOMA 13/50 32/50 28/50 42/50 OR CARCINOMA 13/50 15/50 23/50 8/50 COMBINED 24/50 38/50 38/50 44/50	Neoplastic Lesions
No	TR-457	599-79-1	Salicylazosulfapyridine	Rats	F344/N	Female	Gavage	Urinary Bladder	Some Evidence	Some Evidence	TRANSITIONAL CELL PAPILLOMA 0/49 0/50 2/50 0/50	Neoplastic Lesions
No	TR-457	599-79-1	Salicylazosulfapyridine	Rats	F344/N	Male	Gavage	Urinary Bladder	Some Evidence	Some Evidence	(CORE STUDY) TRANSITIONAL CELL PAPILLOMA 0/50 0/49 2/50 6/50	Neoplastic Lesions